Overcoming obstacles to develop effective and safe siRNA therapeutics
Author:
Affiliation:
1. siRNA Therapeutics, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60031, USA
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1517/14712590902911420
Reference59 articles.
1. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
2. RNAi
3. RNA interference is mediated by 21- and 22-nucleotide RNAs
4. Role for a bidentate ribonuclease in the initiation step of RNA interference
5. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The emerging potential of siRNA nanotherapeutics in treatment of arthritis;Asian Journal of Pharmaceutical Sciences;2023-09
2. Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics;Pharmaceutics;2022-08-03
3. Effect of the array of amines on the transfection efficiency of cationic peptidomimetic lipid molecules into neural cells;RSC Advances;2022
4. Importance of Silencing RNAs in Cancer Research;Handbook of Oxidative Stress in Cancer: Mechanistic Aspects;2022
5. Importance of Silencing RNAs in Cancer Research;Handbook of Oxidative Stress in Cancer: Mechanistic Aspects;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3